Altimmune ALT Stock
Altimmune Price Chart
Altimmune ALT Financial and Trading Overview
| Altimmune stock price | 5.06 USD |
| Previous Close | 4.05 USD |
| Open | 4.08 USD |
| Bid | 0 USD x 4000 |
| Ask | 0 USD x 3100 |
| Day's Range | 4 - 4.13 USD |
| 52 Week Range | 3.82 - 23.49 USD |
| Volume | 1.57M USD |
| Avg. Volume | 2.22M USD |
| Market Cap | 201.61M USD |
| Beta (5Y Monthly) | -0.065492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | January 20, 2017 |
| 1y Target Est | 25.14 USD |
ALT Valuation Measures
| Enterprise Value | 32.45M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.8097346 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | -2551.9634 |
| Price/Book (mrq) | 1.2018807 |
| Enterprise Value/Revenue | -410.82 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Altimmune Stock Price History
| Beta (5Y Monthly) | -0.065492 |
| 52-Week Change | -54.65% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 23.49 USD |
| 52 Week Low | 3.82 USD |
| 50-Day Moving Average | 4.63 USD |
| 200-Day Moving Average | 10.31 USD |
ALT Share Statistics
| Avg. Volume (3 month) | 2.22M USD |
| Avg. Daily Volume (10-Days) | 1.6M USD |
| Shares Outstanding | 49.29M |
| Float | 42.61M |
| Short Ratio | 6.7 |
| % Held by Insiders | 0.83% |
| % Held by Institutions | 92.84% |
| Shares Short | 9.08M |
| Short % of Float | 21.12% |
| Short % of Shares Outstanding | 18.42% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 111562.02% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.050% |
| Return on Equity (ttm) | -48.41% |
Income Statement
| Revenue (ttm) | -79000 USD |
| Revenue Per Share (ttm) | -0.002 USD |
| Quarterly Revenue Growth (yoy) | -34.39% |
| Gross Profit (ttm) | -70520000 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -85357000 USD |
| Diluted EPS (ttm) | -1.78 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 165.73M USD |
| Total Cash Per Share (mrq) | 3.36 USD |
| Total Debt (mrq) | 1.02M USD |
| Total Debt/Equity (mrq) | 0.61 USD |
| Current Ratio (mrq) | 11.579 |
| Book Value Per Share (mrq) | 3.403 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -68467000 USD |
| Levered Free Cash Flow (ttm) | -47639752 USD |
Profile of Altimmune
| Country | United States |
| State | MD |
| City | Gaithersburg |
| Address | 910 Clopper Road |
| ZIP | 20878 |
| Phone | 240 654 1450 |
| Website | https://altimmune.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 52 |
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Q&A For Altimmune Stock
What is a current ALT stock price?
Altimmune ALT stock price today per share is 5.06 USD.
How to purchase Altimmune stock?
You can buy ALT shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Altimmune?
The stock symbol or ticker of Altimmune is ALT.
Which industry does the Altimmune company belong to?
The Altimmune industry is Biotechnology.
How many shares does Altimmune have in circulation?
The max supply of Altimmune shares is 77.01M.
What is Altimmune Price to Earnings Ratio (PE Ratio)?
Altimmune PE Ratio is now.
What was Altimmune earnings per share over the trailing 12 months (TTM)?
Altimmune EPS is -1.34 USD over the trailing 12 months.
Which sector does the Altimmune company belong to?
The Altimmune sector is Healthcare.
Altimmune ALT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Global Market Composite NQGM | 1854.61 USD — |
+0.81
|
— — | 1835.2 USD — | 1871.93 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4184.77 USD — |
+1.29
|
— — | 4144.83 USD — | 4202.15 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4157.43 USD — |
+0.21
|
— — | 3927.42 USD — | 4157.43 USD — | — - | — — |
- {{ link.label }} {{link}}